Evidence map›Paper›PMID 40082705›Full record

ArticleCommunications chemistry2025

Rational engineering of a thermostable α-oxoamine synthase biocatalyst expands the substrate scope and synthetic applicability.

Ben Ashley, Sam Mathew, Mariyah Sajjad, Yaoyi Zhu, Nikita Novikovs, Arnaud Baslé, Jon Marles-Wright, Dominic J Campopiano

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Chemoenzymatic synthesis.Communications chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ben AshleySchool of Chemistry, University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh, UK.
Sam MathewSchool of Chemistry, University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh, UK.
Mariyah SajjadSchool of Chemistry, University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh, UK.
Yaoyi ZhuSchool of Chemistry, University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh, UK.
Nikita NovikovsSchool of Chemistry, University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh, UK.
Arnaud BasléBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Jon Marles-WrightBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Dominic J CampopianoSchool of Chemistry, University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh, UK. Dominic.Campopiano@ed.ac.uk.ORCID http://orcid.org/0000-0001-8573-6735

Funding

RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/J01446X/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/T016841/1
6 · The paper itself

Abstract

Carbon-carbon bond formation is one of the key pillars of organic synthesis. Green, selective and efficient biocatalytic methods for such are therefore highly desirable. The α-oxoamine synthases (AOSs) are a class of pyridoxal 5'-phosphate (PLP)-dependent, irreversible, carbon-carbon bond-forming enzymes, which have been limited previously by their narrow substrate specificity and requirement of acyl-CoA thioester substrates. We recently characterized a thermophilic enzyme from Thermus thermophilus (ThAOS) with a much broader substrate scope and described its use in a chemo-biocatalytic cascade process to generate pyrroles in good yields and timescales. Herein, we report the structure-guided engineering of ThAOS to arrive at variants able to use a greatly expanded range of amino acid and simplified N-acetylcysteamine (SNAc) acyl-thioester substrates. The crystal structure of the improved ThAOS V79A variant with a bound PLP:L-penicillamine external aldimine ligand, provides insight into the properties of the engineered biocatalyst.

Identifiers

PMID40082705
PMCPMC11906848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.